Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Gogolok

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2018
STAR: A Simple TAL Effector Assembly Reaction Using Isothermal AssemblySabine Gogolok, Ute Köber, Steven M Pollard
Scientific Reports|September 13, 2016
STAR: a simple TAL effector assembly reaction using isothermal assemblySabine Gogolok, Claudia Garcia-Diaz, Steven M Pollard
Stem Cell Reports|November 12, 2019
Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription FactorsMantas Matjusaitis, Laura J Wagstaff, Andrea Martella, et al.
Development (Cambridge, England)|January 19, 2017
Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cellsRaul Bardini Bressan, Pooran Singh Dewari, Maria Kalantzaki, et al.
Elife|December 20, 2017
Distinct SoxB1 networks are required for naïve and primed pluripotencyAndrea Corsinotti, Frederick Ck Wong, Tülin Tatar, et al.
Genes & Development|May 4, 2017
Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulatorsHarry Bulstrode, Ewan Johnstone, Maria Angeles Marques-Torrejon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.
Plos One|November 9, 2013
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1Davide Danovi, Amos Folarin, Sabine Gogolok, et al.
Nature|April 8, 2026
Synthetic super-enhancers enable precision viral immunotherapyUte Koeber, Mantas Matjusaitis, Neza Alfazema, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2018
STAR: A Simple TAL Effector Assembly Reaction Using Isothermal AssemblySabine Gogolok, Ute Köber, Steven M Pollard
Scientific Reports|September 13, 2016
STAR: a simple TAL effector assembly reaction using isothermal assemblySabine Gogolok, Claudia Garcia-Diaz, Steven M Pollard
Stem Cell Reports|November 12, 2019
Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription FactorsMantas Matjusaitis, Laura J Wagstaff, Andrea Martella, et al.
Development (Cambridge, England)|January 19, 2017
Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cellsRaul Bardini Bressan, Pooran Singh Dewari, Maria Kalantzaki, et al.
Elife|December 20, 2017
Distinct SoxB1 networks are required for naïve and primed pluripotencyAndrea Corsinotti, Frederick Ck Wong, Tülin Tatar, et al.
Genes & Development|May 4, 2017
Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulatorsHarry Bulstrode, Ewan Johnstone, Maria Angeles Marques-Torrejon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2013
Anticancer effects of niclosamide in human glioblastomaAnja Wieland, Daniel Trageser, Sabine Gogolok, et al.
Plos One|November 9, 2013
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1Davide Danovi, Amos Folarin, Sabine Gogolok, et al.
Nature|April 8, 2026
Synthetic super-enhancers enable precision viral immunotherapyUte Koeber, Mantas Matjusaitis, Neza Alfazema, et al.
Pageof 1